Abstract
Cancer stem-like cell markers are reported be related to the prognosis of various cancers. The aim of this study was to investigate the clinical significance of stem-like cell markers in papillary thyroid carcinoma (PTC). Methods: We constructed tissue microarrays with 386 PTC cases. The expression of cancer stem-like cell markers was estimated using immohistochemical (IHC) staining for CD24, CD15, CD166, CD44, and ALDH1A1. The scores of IHC staining was calculated by multiplying the proportion of stained cells and immunostaining intensity, and was defined positive when the final score was >10. Associations between the expression of cancer stem-like cell markers between the clinicopathologic parameters were evaluated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
